undefined
EUTM file information

017012857

PEFYO

July 20, 2017

Trademark Summary

The trademark PEFYO was filed by GW Research Limited, a corporation established under the laws of the United Kingdom of Great Britain and Northern Ireland (the "Applicant"). The application was published for oppositions on August 15, 2017, and received one opposition filed on November 15, 2017 by Novartis AG on Likelihood of confusion. the opponent was represented by FRIEDRICH GRAF VON WESTPHALEN & PARTNER MBB and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued November 15, 2017

The application was filed in English, and English was also language of all opposition proceedings (German was selected as the second language).

Appointment and Replacement of representative of the trademark registration was recorded on November 15, 2017. Appointment and Replacement of representative of the trademark registration was recorded on December 5, 2019. Appointment and Replacement of representative of the trademark registration was recorded on November 15, 2021. Appointment and Replacement of representative of the trademark registration was recorded on January 11, 2022.

Goods And Services

  • The mark was filed in class 5 with following description of goods:
    1. Pharmaceutical and veterinary preparations and substances
    2. Pharmaceutical preparations and substances
    3. Pharmaceutical and veterinary preparations and substances for the treatment of neurological diseases and conditions
    4. Pharmaceutical and veterinary preparations and substances for the treatment of epilepsy, convulsions and seizures
    5. Pharmaceutical preparations and substances for the treatment of epilepsy
    6. Anti-epileptic pharmaceutical preparations
    7. Pharmaceutical preparations and substances for the treatment of epilepsy, convulsions, seizures, dravet syndrome, lennox-gastaut syndrome, intractable childhood epilepsy with generalized tonic-clonic seizures, generalized epilepsy with febrile seizures plus, doose syndrome and chromosome disorders
    8. Oral anti-epileptic pharmaceutical preparations
    9. All of the aforesaid being cannabinoid medicines
    10. Plants and herbs for medicinal purposes
    11. Medicinal herbs
    12. Extracts of medicinal plants
    13. Plant extracts for pharmaceutical purposes
    14. Medicinal oils
    15. Medicinal infusions
    16. Medicinal infusions for the treatment of epilepsy
    17. Pure extracts of medicinal plants and herbs
    18. Pure extracts of medicinal plants and herbs used for the treatment of epilepsy, convulsions and seizures
    19. Foodstuffs for medicinal purposes
    20. Herb teas for medicinal purposes
    21. Dietary supplements and dietetic preparations.
  • The mark was filed in class 31 with following description of goods:
    1. Agricultural and horticultural products
    2. Seeds
    3. Seedlings for plant breeding
    4. Flowers
    5. Plants
    6. Plant residues (raw materials).